Latest Form 4 insider transactions

NASDAQ
Richard Kuntz, a Director of Identiv, Inc., received 17,544 shares of common stock on July 30, 2026.
NASDAQ
Alexander L Cappello, a Director of Cheesecake Factory Inc, sold 2,254 shares of common stock on July 30, 2026.
NASDAQ
Laura Angelini, a Director of Identiv, Inc., received 18,797 shares of common stock on July 30, 2026.
NASDAQ
Kevin M O'Connor, President of Hanover Bancorp, Inc. /NY, purchased 10,000 shares of common stock on July 30, 2026 for $26.88 per share.
NASDAQ
Gary Kremen, a Director of Identiv, Inc., received 15,664 shares of common stock on July 30, 2026.
NASDAQ
James E Ousley, a Director of Identiv, Inc., received 23,810 shares of common stock on July 30, 2026.
NASDAQ
Stephanie Stahl, a Director of Dollar Tree, Inc., reported multiple transactions in common stock on August 1, 2026.
NYSE
Michael George Rosenbaum, Chief Executive Officer and a Director of Guidewire Software, Inc., sold 1,200 shares of common stock on August 3, 2026 for $155.92 per share.
NASDAQ
Aditya Maheshwari, Chief Accounting Officer of Dollar Tree, Inc., reported a transaction in 127 shares of common stock on August 2, 2026.
NASDAQ
Mary Jayne Crocker, a Director of Bridgewater Bancshares Inc, sold 11 shares of common stock on July 30, 2026 for $21.21 per share.
NASDAQ
David J. Lee, See Remarks and a Director of WEBTOON Entertainment Inc., reported a transaction in 2,954 shares of common stock on August 1, 2026.
NASDAQ
Susan Bobulsky, Chief Commercial Officer, MRD of Adaptive Biotechnologies Corp, sold 1,299 shares of common stock on July 30, 2026 for $24.00 per share.
NASDAQ
Jessica Anne Stejskal, Chief Experience Officer of Bridgewater Bancshares Inc, reported multiple transactions in common stock on July 30, 2026.
Adam L. Rosman, Chief Admin. and Legal Officer of Fiserv Inc, received 36,799 shares of common stock on August 3, 2026.
NASDAQ
Frank D Yeary, a Director of Mobileye Global Inc., purchased 12,360 shares of common stock on July 30, 2026 for $7.98 per share.
NYSE
Robert Mionis, Chief Executive Officer and a Director of Celestica Inc, sold 9,543 shares of common stock on July 31, 2026.
NYSE
Lauren Patricia Flaherty, a Director of Brunswick Corp, received 562 shares of common stock on July 31, 2026.
NYSE
Reginald Fils-Aime, a Director of Brunswick Corp, received 601 shares of common stock on July 31, 2026.
NYSE
Roger Wood, a Director of Brunswick Corp, received 585 shares of common stock on July 31, 2026.
NYSE
David C Everitt, a Director of Brunswick Corp, received 740 shares of common stock on July 31, 2026.
NYSE
David Singer V, a Director of Brunswick Corp, received 1,046 shares of common stock on July 31, 2026.
NYSE
Maryann Wright, a Director of Brunswick Corp, received 581 shares of common stock on July 31, 2026.
NYSE
Joseph W Mcclanathan, a Director of Brunswick Corp, received 562 shares of common stock on July 31, 2026.
NYSE
J Steven Whisler, a Director of Brunswick Corp, received 1,026 shares of common stock on July 31, 2026.
NYSE
Nancy E Cooper, a Director of Brunswick Corp, sold 206 shares of common stock on July 31, 2026 for $78.45 per share.
NYSE
Mandeep Chawla, Chief Financial Officer of Celestica Inc, sold 883 shares of common stock on July 31, 2026.
NASDAQ
William M Lyons, a Director of Morningstar, Inc., sold 1,000 shares of common stock on August 3, 2026 for $199.00 per share.
NASDAQ
Carmine N. Stengone, CEO and President and a Director of Contineum Therapeutics, Inc., sold 2,500 shares of common stock on August 3, 2026 for $16.01 per share.
NASDAQ
Michael Chen, Chief Legal Officer of Newegg Commerce, Inc., sold 67 shares of common stock on July 29, 2026 for $12.74 per share.
NYSE
David Patrick Michels, VP and Chief Financial Officer of Kinder Morgan, Inc., reported multiple transactions in common stock on July 31, 2026.